Evidence map›Paper›PMID 34703803›Full record

ArticleClinical and experimental vaccine research2021

Adverse events following pediatric immunization in an Indian city.

Varun Paramkusham, Prashanth Palakurthy, Navya Sri Gurram, Varun Talla, Hunsur Nagendra Vishwas, Venkateshwar Rao Jupally, Satyanarayan Pattnaik

Open access · diamondAbstract read
In one paragraph

Article in Clinical and experimental vaccine research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Varun ParamkushamDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0002-8284-6485
Prashanth PalakurthyDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0002-2422-9761
Navya Sri GurramDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0002-1387-7448
Varun TallaDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0003-4173-1443
Hunsur Nagendra VishwasDepartment of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, India.ORCID https://orcid.org/0000-0003-4132-3028
Venkateshwar Rao JupallyDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0001-9548-1932
Satyanarayan PattnaikDepartment of Clinical Pharmacy, Talla Padmavathi College of Pharmacy, Warangal, India.ORCID https://orcid.org/0000-0002-3113-6926
Sri Padmavati Mahila Visvavidyalayam · INJSS Academy of Higher Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdverse effects are noticeable immediately after vaccination, especially when vaccinated to healthy people at the time of vaccination. The vaccine may cause adverse events which are very rare but adverse event following immunization surveillance becomes correspondingly more important in a less studied population like India. Hence, there is a need for carrying out a study pertaining to vaccine safety in the pediatric population of age 0-12 years and assessing the events occurring post-vaccination. MATERIALS AND

methodsA prospective observational study was conducted in three primary healthcare centers and two tertiary care hospitals for 6 months from April 2016 to September 2016 with a total of 826 children enrolled. Detected adverse events for suspected vaccines were analyzed for causality by the World Health Organization causality assessment instrument. Sex-specific differences in incidences of adverse events were assessed.

resultsThe cumulative adverse events were found highest in pentavalent vaccines (510 incidences, 62.04%) followed by the bacillus Calmette-Guérin vaccine (189 incidences, 22.99%). The study didn't reveal any significant association in incidences of adverse events following immunization and sex of the children.

conclusionVaccine safety surveillance studies are need of the hour in developing countries to maintain public trust in vaccines, the ultimate objective being to have vaccines with the most favorable benefit-risk profile. The present study discussed the various adverse events following immunization and suggested the absence of any sex-specific difference in incidences of adverse events in children.

Indexed as

CausalityImmunizationInjection site adverse eventPharmacovigilanceVaccinationVaccine

Identifiers

PMID34703803
PMCPMC8511592
OpenAlexW3207305310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.